Precision Medicine for Localized Prostate Cancer: Time to Move Beyond NCCN Risk Stratification?

Zumsteg, Zachary S

Precision Medicine for Localized Prostate Cancer: Time to Move Beyond NCCN Risk Stratification? [electronic resource] - International journal of radiation oncology, biology, physics 01 2019 - 92-94 p. digital

Publication Type: Editorial; Comment

1879-355X

10.1016/j.ijrobp.2018.09.040 doi


Genomics
Humans
Male
Precision Medicine
Prostatic Neoplasms
Radiotherapy, Image-Guided